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Abstract
Background: Patients with a diagnosis of schizophrenia are socially excluded. The aim of this study was to investigate how
patients participate in first encounters with unfamiliar healthy participants, who are unaware of their diagnosis.
Methods: Patterns of participation were investigated during interactions involving three-people. Three conversation roles
were analysed: (i) speaker, (ii) primary recipient- focus of the speaker’s attention and (iii) secondary recipient- unaddressed
individual. Twenty patient interactions (1 patient, 2 healthy controls) and 20 control interactions (3 healthy participants)
were recorded and motion captured in 3D. The participation of patients and their partners, in each conversation role, was
compared with controls at the start, middle and end of the interaction. The relationship between patients’ participation,
their symptoms and the rapport others experienced with them was also explored.
Results: At the start of the interaction patients spoke less (ß=2.639, p= .02) and spent more time as secondary recipient
(ß= .349, p= .02). Patients’ participation at the middle and end of the interaction did not differ from controls. Patients’
partners experienced poorer rapport with patients who spent more time as a primary recipient at the start of the interaction
(Rho(11) =2.755, p,.01). Patients’ participation was not associated with symptoms.
Conclusion: Despite their increased participation over time, patients’ initial participation appears to be associated with
others’ experience of rapport with them. Thus, the opening moments of patients’ first encounters appear to be
interpersonally significant. Further investigation of patient and others’ behaviour during these critical moments is warranted
in order to understand, and possibly develop interventions to address, the difficulties schizophrenia patients experience
here.
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Introduction
A prominent feature of schizophrenia is patients’ social
exclusion. Patients have smaller social networks, less satisfactory
interpersonal relationships and greater unemployment than
healthy people or patients with other psychiatric disorders [1,2].
A central and debilitating feature of schizophrenia, which may
contribute to patients’ social exclusion, is patients’ difficulty
interacting with others. These social deficits are poorly under-
stood. Patients display poor performance on ‘off-line’ assessments
of social cognition, which investigates the ability to discriminate
facial expressions in pictures, attribute emotional states to the
protagonists in short narratives and infer intentions in abstract
problem solving contexts [3]. However, how patients’ social
deficits manifest during their ‘on-line’ social interactions with
others remains largely unexplored.
Early psychiatrists described feeling an intuitive ‘lack of rapport’
when interacting with a patient with schizophrenia, which was
termed the ‘Praecox feeling’ [4]. According to Ru¨mke (1941) the
praecox feeling is based on patients’ nonverbal behaviour. This
may extend beyond patients’ clinical interactions and influence
their everyday social interactions. Indeed, a recent study revealed
that patients’ nonverbal behaviour (e.g. hand and head movement)
during first encounters with unfamiliar others, influenced others’
experience of rapport with the patient [5]. This was the case even
though others were unaware of the patient’s diagnosis. Thus,
alongside stigma due to others’ knowledge of the disorder, patients’
behaviour during social interactions may contribute to others’
experience of the interaction.
The aim of this study is to assess patients’ participation during
first encounters with others. The study of three-person interactions
provides an ideal interaction setting in that, unlike two-person
interactions where individuals are obliged to take the role of the
speaker or hearer, two hearer roles are possible: (i) a primary
recipient: the individual who the speaker is addressing and
directing their speech towards and (ii) a secondary recipient: a fully
ratified participant who the speaker is not currently addressing
[6,7]. The speaker and primary recipient form the ‘active pair’,
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sharing a particular relationship with increased mutual gaze and
coordinated movement, which the unaddressed, secondary recip-
ient is not party to [7,8].
Here we investigate how, during first encounters, patients
participate in interactions with two others who are unaware of
their diagnosis. In line with previous studies investigating
multiparty interaction, the identity of primary and secondary
recipients in the current study will be approximated from speakers’
head angle, using 3-D motion capture data [5,7,9]. The
relationship between patients’ participation, their symptoms and
the rapport their partners experience with them will also be
explored.
Methods
Ethics Statement
All procedures were approved by the Charing Cross Research
Ethics Committee (London, UK: 07/H0711/90) and all partic-
ipants provided written informed consent.
Study Design
The current study is a secondary analysis of data collected to
investigate social interaction in schizophrenia [5]. The corpus
under analysis involved three-way interactions in two conditions:
A patient condition, involving one patient with a diagnosis of
schizophrenia and two healthy participants (i.e. patients’ partners),
and a control condition, involving three healthy participants (i.e.
controls). This study analysed the amount of time participants
spent as a speaker, primary and secondary recipients.
Sample
Twenty patients with a diagnosis of schizophrenia (6 male, 14
female) and one hundred non-psychiatric healthy participants,
forty in the patient condition (21 male, 19 female) and sixty in the
control condition (34 male, 26 female), participated in the study.
Recruitment and data collection occurred from July 2008 to Nov
2010. Patients were recruited at routine psychiatric outpatient
clinics, on the basis of a clinical diagnosis of schizophrenia. Of all
patients approached, 25% agreed to participate. Diagnosis was
confirmed using the Structured Clinical Interview for DSM-IV
symptoms [10]. Patients presenting with motor side effects from
anti-psychotic medication (e.g. muscle stiffness and involuntary
muscle spasms) were excluded from the study based on clinicians’
assessment. Patients’ antipsychotic medication was documented
and converted into chlorpromazine equivalents (CPZE mg/day)
according to the standard formula suggested by Woods [11].
Non-fluent English speakers were also excluded. Non-psychiat-
ric healthy participants were recruited through advertising on local
community websites. Of those who responded to the advertise-
ment, 40% participated. Participants with a diagnosis of psychosis
or affective disorders in themselves, or any first-degree relatives,
and those who were not fluent English speakers were excluded.
Interacting participants had not met prior to the study. Healthy
participants were informed that the study was an investigation of
social interaction, and were not aware that a psychiatric patient
was present. All interactions were conducted outside of a
psychiatric department, i.e. in a non-medical university depart-
ment. After complete description of the study to the subjects,
written informed consent was obtained.
Assessments
Patients’ diagnosis of schizophrenia, paranoid subtype, was
confirmed using the Structured Clinical Interview for Diagnostic
symptoms (SCID-I) [10]. Patients’ positive, negative and general
symptoms were assessed using the Positive And Negative
Syndrome Scale for schizophrenia (PANSS) [12]. The Brixton
Spatial Anticipation Test and the Hayling Sentence Completion
Test assessed participants executive functioning [13]. Participants
rated the level of rapport or connection they felt with each
interacting partner on a 10 point scale, with a higher score
indicating stronger rapport [14].
3D Motion-capture Equipment
The Augmented Human Interaction laboratory, where inter-
actions were recorded, was fitted with an optical based Vicon
motion-capture system, consisting of 12 infrared cameras and
Vicon iQ software. Participants wore a top and cap with 27
reflective markers attached. The motion capture system detected
the precise spatial and temporal coordinates of participants’
markers in 3D at each frame of the interaction, at a rate of 60
frames per second. This information was exported in numerical
values and as a wire-frame representation of the interaction over
time.
Procedure
Each group of three participants were seated and asked to
discuss a moral dilemma called ‘The Balloon Task’ [15]. During a
one-to-one interview with a researcher, all participants’ socio-
demographic and executive functioning was assessed. Patients’
clinical features and social functioning were also assessed. A
detailed description of the procedure is described elsewhere [5].
Identification of speaker and hearers. The identification
of the speaker, primary and secondary recipients was assessed on a
frame-by-frame basis. Speakers were hand coded from 2D videos
using ELAN annotational software [16]. Primary recipients were
identified as the person the speaker was oriented towards.
Speakers’ head orientation was determined based on the precise
spatial coordinates of the four optical markers attached to their
caps (see figure 1) [7]. This procedure has been used in previous
studies to index listener role in three-way interactions [7]. Frames
with speaker head orientations falling less than two degrees from
the centre line were excluded from the analysis (15% of the data
set) to eliminate ambiguity.
Statistical Analysis
Statistical analyses were conducted using SPSS Version 20 (
Copyright SPSS Inc. 2010). Independent samples t-tests were used
to compare interaction duration (in seconds) between conditions,
and age and executive functioning between patients and healthy
participants. Chi 2-tests compared: the distribution of gender
across conditions (i.e. patient condition (n=60) and control
condition (n=60) and between patients (n=20) and healthy
participants (n = 100).
Conversation role. In order to identify change in conversa-
tional roles over time, the percentage of time spent in each role
was assessed at three time points during the interaction (i.e. the
start, middle and end of the interaction). In order to adjust for the
variations in total interaction duration between groups, each
interaction was divided into ten sections based on the interaction
duration (i.e. interaction duration (seconds)/10). Each section had
a mean duration of approximately 30 seconds. The percentage of
time participants spent in each conversation role was calculated at
sections one (interaction start: approximately 0–30 seconds) five
(interaction middle: approximately 120–150 seconds) and eight
(interaction end: approximately 210–240 seconds). The final two
sections (approx 1 minute) of the interactions were not analysed as
observations revealed a trailing off during this final minute, so
patterns of participation may be misrepresented in this data.
Social Participation in Schizophrenia
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Mixed models analyses compared percentage of time spent in
each conversation role between the three participant types
(patient, patients’ partners and controls) at the start (section 1),
middle (section 5) and end (section 8) of the interaction, clustering
for the three-person group participants belonged to. Participants’
age, gender and executive functioning were accounted for in the
model and reported if significant.
Patients’ conversation role, clinical features and
rapport. Spearman-Rho nonparametric correlation coefficients
(two-tailed) assessed the relationship between percentage of time
patients spend in each conversation role (speaker, primary
recipient and secondary recipient) and patients’ symptoms
(PANSS), antipsychotic medication dose (CPZE), and the rapport
others experience with them. Significant associations were further
investigated using regression analyses.
Results
Interactions lasted on average 5 minutes 24 seconds (SD=1
minute 55 seconds). The duration of interactions in the patient
condition (M=318.08 sec, SD=113.35) did not differ from the
control condition (M=335.29 sec, SD=118.91) (t(38) =24.62,
p = .65).
The distribution of gender in the patient condition (n=60:
female = 53.33%) and control condition (n=60: female = 43.33%)
did not significantly differ (X2 (1) = 1.20, p = .27). The distribution
of gender within patients (n=20: female = 65%) and healthy
participants (n = 100: female = 45%) did not significantly differ (X2
(1) = 2.67, p= .10). Participants’ age and scores on assessments of
executive functioning are displayed in table 1. Compared to
healthy participants, patients were older (p,.01) and displayed
poorer executive functioning (p,.01).
Patients’ Clinical Features
Patients’ mean duration of illness was 15 years (SD=10.26;
range 2–46 years), with an average inpatient admissions duration
of 19.95 weeks (SD=18.45; range 0–60). Patients’ mean symptom
scores were: positive 15.80 (SD=6.76; range 7–37) negative 9.95
(SD=3.36; range 7–19) and general symptoms 28.41 (SD=10?42;
range 16–59). Three patients were medication free at the time of
the study and the remaining seventeen were taking typical (2
patients) or atypical (15 patients) antipsychotic medication. Of
those taking antipsychotic medication, the average dose was
167.87 mg/day (SD=109.29; range 50–400 mg/day), which fell
within the low dose range (CPZE=50–200 mg/day) [17].
Conversation Role
Mixed models comparisons of conversation role, by participant
type, at each time interval are displayed in table 2. At the start of
the interaction, compared to participants in the control group,
patients spent less time speaking (ß=2.639, p= .02) and more
time in the role of secondary recipient (ß= .349, p= .02), while
patients’ partners spent less time as a secondary recipient
(ß=2.357, p= .02). Compared to male participants, female
participants spent more time in role of secondary recipient at
the start of the interaction (p= .01), and less time as a primary
recipient at the end of the interaction (p= .05). Patients or their
partners did not differ from controls in the amount of time they
spent in any conversation role at the middle or end of the
interaction (p..05). Figure 2 displays the mean percentage of time
spent as speaker and secondary recipient at each time point, by
participant type.
Conversation role and clinical features. Spearman-Rho
correlations found no significant association between the time
patients spent in each conversation role (start middle or end) and
their symptoms (positive, negative or general) (p..05) or antipsy-
chotic medication dose (p..05).
Conversation role and rapport. Spearman-Rho correlation
revealed that patients’ partners experienced poorer rapport with
patients who, at the start of the interaction, spent less time in the
role of secondary recipient (Rho(11) = .705, p= .02) and more time
in the role of primary recipient (Rho(11) =2.755, p,.01).
Discussion
The findings revealed that, at the start of a first encounter,
patients spoke less and spent more time as a secondary recipient.
However, as the interaction progressed patients’ participation in
the conversation did not differ from controls. Patients’ partners
experienced poorer rapport with patients who, at the start of the
interaction, spent more time as the focus of the speaker’s attention,
in the role of primary recipient. Patients’ symptoms were not
associated with their participation at any time interval.
In the opening moments of the interaction, patients spent less
time speaking and more time in the role of secondary recipient.
This suggests that patients are taking a more peripheral role at the
start of the interaction, speaking, and being spoken to, less. In line
with these findings, previous studies identified that schizophrenia
patients show increased ‘flight’ behaviour, signaling the avoidance
of social stimuli, during the first two minutes of a clinical
consultation [18]. Thus, it appears that schizophrenia patients
display signs of social withdrawal at the start of an interaction.
Patients may find participating in a face-to-face interaction
demanding due to social anxiety. This may have implications for
devising interventions to address patients’ initial difficulties settling
into a conversation with others, both in and outside of clinical
contexts.
Differences between patients and controls were identified after
adjusting for gender. However, investigation across all participants
revealed differences in participation between gender. Specifically,
compared to males, females were more likely to be secondary
Figure 1. Indexing primary and secondary recipient from the
head angle of the speaker. Speaker’s head angle is derived from the
precise positions (3D) of the four reflective markers attached to their
cap.
doi:10.1371/journal.pone.0077506.g001
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recipients at the start of the interaction and less likely to be
primary recipients at the end. The size of the patient sample in the
current study was insufficient to investigate any interaction effects
for patient and gender. However, this should be considered in
future studies.
Patients’ participation at the middle or end of the interaction
did not differ from healthy participants in the control condition.
This suggests that over the course of an interaction, patients
become more actively involved as a speaker and spend less time in
the role of secondary recipient. Micro-analyses of patients’ three-
way interactions has found that when patients are reluctant to
speak, others actively attempt to involve them in interaction:
initially using subtle nonverbal cues and, if unsuccessful, verbally
requesting their input [19]. Perhaps patients’ increased involve-
ment over the course of the interaction is a result of both others
actively attempting to engage the patient and patients becoming
more comfortable in the interaction. Patients’ increased partici-
pation over time suggests that, rather than patients being excluded
from the speaker-primary recipient pair over the course of a first
meeting, patients initially appear to participate less but become
more involved as the interaction progresses.
Others’ experience of rapport with the patient was associated
with patients’ participation at the start of the interaction
(approximately the first 30 seconds). Specifically, others experi-
enced poorer rapport with patients who spent more time in the
role of primary recipient and less time as secondary recipient. This
suggests that patients’ partners are detecting something in the
patient’s behaviour at the start of the interaction that is making
them more likely to be the focus of their attention (i.e. primary
recipient). In a previous analysis of this corpus, patients’ increased
hand movement during interaction was associated with others’
poorer experience of rapport with them [5]. Thus, despite the fact
that patients’ participation improves over time, it appears that the
opening moments of patients’ first encounters are interpersonally
important. Future research should further investigate other aspects
of patients’ behaviour (e.g., what they are saying, their nonverbal
behaviour) and their partners’ responses to them at this critical
phase in the interaction. Moreover, understanding how patterns of
participation develop over longer and repeat encounters would
also be of relevance in understanding social integration of patients.
The current study found no association between patients’
participation in conversation and their symptoms. It might have
been expected that patients with more negative symptoms would
Table 1. Age and executive functioning by participant type.
Schizophrenia patients
(n =20) Healthy participants (n =100)
Variables M SD M SD t df p
Age 41.50 8.64 31.10 9.60 24.51 119 ,.01
Spatial Executive functioning 3.07 0.51 5.10 0.22 3.65 119 ,.01
Verbal Executive functioning 3.79 0.43 4.91 0.18 2.52 119 ,.01
doi:10.1371/journal.pone.0077506.t001
Figure 2. Mean percentage of time spent as speaker (A) and secondary recipient (B) at the start, middle and end of the interaction
by participant type.
doi:10.1371/journal.pone.0077506.g002
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Table 2. Mixed models analyses investigating the percentage of time spent in each conversation role by participant type at the
start, middle and end of the interaction.
95% CI
Models n M (%) SE ß SE Lower Upper Chi2 df p
Interaction start
1. Speaking
Patients 20 17.35 3.81 2.639 .28 21.186 2.093 5.26 1 .02
Patients’ partners 40 33.22 1.73 .141 .10 2.072 .355 1.68 1 .19
Controls 60 29.97 0.94
2. Primary
Patients 20 21.96 3.70 2.197 .23 2.657 .264 0.70 1 .40
Patients’ partners 40 26.27 2.37 2.111 .14 2.377 .155 0.67 1 .41
Controls 60 26.64 0.74
3. Secondary
Patients 20 36.38 5.36 .349 .15 .054 .645 5.36 1 .02
Patients’ partners 40 17.96 2.67 2.357 .15 2.659 2.055 5.36 1 .02
Controls 60 25.66 0.81
Gender: Male 62 20.64 2.20 2.430 .17 2.754 2.107 6.79 1 .01
Gender: Female 58 31.73 2.45
Interaction middle
4. Speaking
Patients 20 26.62 5.58 2.018 .26 2.533 .498 0.01 1 .94
Patients’ partners 40 29.98 2.68 2.069 .12 2.165 .303 0.34 1 .56
Controls 60 29.13 2.62
5. Primary
Patients 20 20.75 3.85 2.305 .21 2.716 .106 2.11 1 .15
Patients’ partners 40 27.38 3.05 .050 .16 2.261 .361 0.10 1 .75
Controls 60 25.68 2.65
6. Secondary
Patients 20 30.41 4.06 .189 .27 2.331 .709 0.51 1 .48
Patients’ partners 40 22.89 3.10 2.002 .14 2.282 .277 0.01 1 .99
Controls 60 25.49 2.84
Interaction end
7. Speaking
Patients 20 25.97 5.22 2.148 .28 2.700 .404 0.28 1 .60
Patients’ partners 40 28.13 2.62 2.040 .12 2.276 .196 0.11 1 .74
Controls 60 30.38 1.11
8. Primary
Patients 20 19.97 4.77 2.239 .29 2.813 .336 0.66 1 .42
Patients’ partners 40 23.98 3.15 2.244 .20 2.645 .157 1.43 1 .23
Controls 60 26.96 0.99
Gender: Male 62 26.90 2.41 .278 .14 .006 .551 4.02 1 .05
Gender: Female 58 20.36 1.85
9. Secondary
Patients 20 27.52 5.12 2.060 .30 2.639 .520 0.04 1 .84
Patients’ partners 40 20.55 2.92 2.130 .17 2.469 .209 0.56 1 .45
Controls 60 26.23 0.81
Key: Patients’ partners – Healthy participants in the patient condition; Controls – Healthy participants in the control condition.
Model 1. Goodness of fit QIC = 68.35; Model 2. Goodness of fit QIC = 74.67; Model 3. Goodness of fit QIC = 119.0.
Model 4. Goodness of fit QIC = 76.00; Model 5. Goodness of fit QIC = 80.57; Model 6. Goodness of fit QIC = 100.19. Model 7. Goodness of fit QIC = 80.91; Model 8.
Goodness of fit QIC = 94.46; Model 9. Goodness of fit QIC = 84.10.
doi:10.1371/journal.pone.0077506.t002
Social Participation in Schizophrenia
PLOS ONE | www.plosone.org 5 October 2014 | Volume 9 | Issue 1 | e77506
spend less time speaking. However, the variance on patients’
symptoms in the current sample was low, which may have
impeded the ability to detect an association if one existed.
Strengths and Limitations
This study benefited from the three-person experimental design,
enabling the investigation of patients’ participation in contexts
more typical of everyday social interaction. Furthermore, by
ensuring all interacting partners were unfamiliar to each other and
unaware of patients’ diagnoses, the possible confounding variables
of familiarity and stigma, due to prior knowledge of the disorder,
were removed. Although the interactions were unscripted conver-
sations, they were recorded in a motion capture lab, which is a
somewhat unnatural environment. Future studies could employ
new motion capture techniques, such as the Kinect system, to
obtain similar data from interactions outside a lab setting [20].
Examining patients’ interactions in more naturalistic environments
may allow for recruitment of patients who are more symptomatic
addressing the limited symptom variance seen in the current study.
As the head angle of primary or secondary recipients was not
investigated we cannot say whether the primary recipient is
returning the gaze of the speaker. Although this was not necessary
to answer the questions of the current study, future studies could
investigate patients’ reciprocation of speakers’ gaze in the role of
primary recipient.
Conclusion
The aim of this study was to investigate schizophrenia patients’
participation during first encounters with unfamiliar others who
were unaware of their diagnosis. The findings indicate that
although patients take a more peripheral role at the start of the
interaction, they participate more as the interaction progresses.
Despite this, it is the first 30 seconds of the encounter that
influences others’ experience of rapport with them. This highlights
the opening moments of patients’ conversations as interpersonally
significant. Future research should identify the precise behaviours
displayed, by patients and others, during this critical period in
order to develop our understanding of patients’ social deficits and
their impact on interpersonal relationships.
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